Erratum: Relative risk versus absolute risk: One cannot be interpreted without the other (Nephrology Dialysis Transplantation DOI: 10.1093/ndt/gfw465);Relative risk versus absolute risk: One cannot be interpreted without the other

Nephrology Dialysis Transplantation

Volumn 32, Issue , 2017, Pages ii13-ii18

  Noordzij, Marlies ^a   Van Diepen, Merel ^b   Caskey, Fergus C ^c   Jager, Kitty J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Absolute risk difference; Epidemiology; Number needed to treat; Relative risk; Risk reduction

Indexed keywords

ABSOLUTE RISK; CANCER RISK; CLINICAL EFFECTIVENESS; CONFIDENCE INTERVAL; END STAGE RENAL DISEASE; ENVIRONMENTAL FACTOR; HAZARD RATIO; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW RISK POPULATION; MORTALITY RISK; NEPHRECTOMY; OUTCOME ASSESSMENT; POPULATION EXPOSURE; PRIORITY JOURNAL; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STATISTICAL SIGNIFICANCE; EPIDEMIOLOGY; STATISTICS;

EPIDEMIOLOGIC STUDIES; HUMANS; RISK; STATISTICS AS TOPIC;

EID: 85019086744     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfab291     Document Type: Erratum

References (18)

1. Rothman KJ. Epidemiology. An Introduction. New York, NY: Oxford University Press, 2002
2. Jager KJ, Zoccali C, Kramar R, et al. Measuring disease occurrence. Kidney Int 2007; 72: 412-415
3. Noordzij M, Leffondre K, van Stralen KJ, et al. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant 2013; 28: 2670-2677
4. van Dijk PC, Jager KJ, Zwinderman AH, et al. The analysis of survival data in nephrology: basic concepts and methods of Cox regression. Kidney Int 2008; 74: 705-709
5. Andersen PK, Geskus RB, de Wiite T, et al. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2013; 2: 861-870
6. Tripepi G, Jager KJ, Dekker FW, et al. Measures of effect: relative risks, odds ratios, risk difference, and 'number needed to treat'. Kidney Int 2007; 72: 789-791
7. Vogelzang JL, van Stralen KJ, Noordzij M, et al. Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry. Nephrol Dial Transplant 2015; 30: 1028-1037
8. http://www.reuters.com/article/us-japan-nuclear-cancer-id USBRE91R0D42 0130228 (10 June 2016, date last accessed)
9. Muzaale AD, Massie AB, Wang MC, et al. Risk of end-stage renal disease following live kidney donation. JAMA 2014; 311: 579-586
10. van Diepen M, Ramspek CL, Jager KJ, et al. Prediction versus aetiology: common pitfalls and how to avoid them. Nephrol Dial Transplant 2017; 32 (Suppl 2): ii1-ii5
11. Bucher HC, Weinbacher M, Gyr K. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ 1994; 309: 761-764
12. Hochman M, Mc Cormick D. Endpoint selection and relative (versus absolute) risk reporting in published medication trials. J Gen Intern Med 2011; 26: 1246-1252
13. Schwartz LM, Woloshin S, Dvorin EL, et al. Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks. BMJ 2006; 333: 1248
14. Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332
15. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c869
16. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147: 573-577
17. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 2007; 147:W163-W194
18. Rao A, Bruck K, Methven S, et al. Quality of reporting and study design of CKD cohort studies assessing mortality in the elderly before and after STROBE: a systematic review. Plo S One 2016; 11: e0155078